Novo Nordisk A/S

NYSE: NVO
Share price (12/20/24): $85.00
Market cap (12/20/24): $379 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

Prospectuses and Registrations Filter

Registration of ADRs

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer

Ownership Filter

Annual report of employee stock purchase, savings and similar

Annual report of employee stock purchase, savings and similar

BlackRock Finance, Inc.

Annual report of employee stock purchase, savings and similar

Annual report of employee stock purchase, savings and similar

News Filter

Share Repurchase Programme

CagriSema Demonstrates Superior Weight Loss in Adults With Obesity or Overweight in the REDEFINE 1 Trial

The Acquisition of Catalent by Novo Holdings, and the Related Acquisition by Novo Nordisk of Three Manufacturing Sites From Novo Holdings, Is Completed

Share Repurchase Programme

The Acquisition of Catalent by Novo Holdings, and the Related Acquisition by Novo Nordisk of Three Manufacturing Sites From Novo Holdings, Is Cleared to Close

Proxies

No filings in this category.

Other Filter

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC